ARTICLE | Company News
Nitto Denko, Quark deal
July 26, 2010 7:00 AM UTC
The companies partnered to develop short interfering RNA (siRNA) therapeutics to treat fibrotic diseases. The therapeutics will be developed using Quark's RNAi technologies and Nitto Denko's drug deli...